Condition

Advanced Squamous Non Small Cell Lung Cancer

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions5

Lead sponsors shown3

Clinical trials

3 shown

Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records DatabasesNCT07485166 · 2026-03-12

ACTIVE_NOT_RECRUITING

AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung CancerNCT05840016 · 2023-08-17

ACTIVE_NOT_RECRUITING

Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLCNCT04497584 · 2021-08-04

ACTIVE_NOT_RECRUITING

Common interventions

Afatinib + PrednisoneDRUG1AK112, Carboplatin, PaxlitaxelDRUG1Initiation of docetaxelDRUG1Initiation of nivolumabDRUG1Tislelizumab, Carboplatin, PaxlitaxelDRUG1

Leading sponsors

Akeso1Brigham and Women's Hospital1University of Texas Southwestern Medical Center1

Trial status mix

ACTIVE_NOT_RECRUITING3

Phase mix

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.